Rhenman & Partners Asset Management Ab Bristol Myers Squibb CO Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $6.7 Million - $7.82 Million	-125,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $12.4 Million - $13.5 Million	-200,000 Reduced 61.54%	125,000 $8.35 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $890,100 - $1 Million	-15,000 Reduced 4.41%	325,000 $20.5 Million
Q4 2020 Jan 19, 2021	BUY	$57.74 - $65.43 $2.89 Million - $3.27 Million	50,000 Added 17.24%	340,000 $21.1 Million
Q3 2020 Oct 13, 2020	SELL	$57.43 - $63.64 $5.17 Million - $5.73 Million	-90,000 Reduced 23.68%	290,000 $17.5 Million
Q2 2020 Jul 16, 2020	BUY	$54.82 - $64.09 $1.64 Million - $1.92 Million	30,000 Added 8.57%	380,000 $22.3 Million
Q1 2020 Apr 16, 2020	BUY	$46.4 - $67.43 $464,000 - $674,300	10,000 Added 2.94%	350,000 $19.5 Million
Q4 2019 Jan 17, 2020	SELL	$49.21 - $64.19 $3.69 Million - $4.81 Million	-75,000 Reduced 18.07%	340,000 $21.8 Million
Q3 2019 Oct 16, 2019	BUY	$42.77 - $50.71 $3.28 Million - $3.89 Million	76,614 Added 22.64%	415,000 $21 Million
Q2 2019 Jul 22, 2019	BUY	$44.62 - $49.34 $4.84 Million - $5.35 Million	108,386 Added 47.12%	338,386 $15.3 Million
Q1 2019 Apr 11, 2019	SELL	$45.12 - $53.8 $6.32 Million - $7.53 Million	-140,000 Reduced 37.84%	230,000 $11 Million
Q4 2018 Feb 05, 2019	BUY	$48.76 - $63.23 $1.95 Million - $2.53 Million	40,000 Added 12.12%	370,000 $19.2 Million
Q3 2018 Oct 03, 2018	SELL	$55.19 - $62.25 $6.07 Million - $6.85 Million	-110,000 Reduced 25.0%	330,000 $20.5 Million
Q2 2018 Jul 20, 2018	BUY	$50.53 - $62.98 $4.55 Million - $5.67 Million	90,000 Added 25.71%	440,000 $24.4 Million
Q1 2018 Apr 11, 2018	BUY	$59.92 - $68.98 $13.2 Million - $15.2 Million	220,198 Added 169.64%	350,000 $22.1 Million
Q4 2017 Jan 19, 2018	SELL	$59.94 - $65.35 $1.84 Million - $2.01 Million	-30,700 Reduced 19.13%	129,802 $7.95 Million
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $8.86 Million - $10.2 Million	160,502	160,502 $10.2 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.2 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.4 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.51 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.62 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.62 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account